Delivery Order SPE2DB20D1109-SPE2DB25FP31X
Award Date 6/30/25
Potential Completion Date 7/1/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML insulin medication. The $18,948.75 firm-fixed-price contract has an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch 200 unit/mL 3mL medication. The contract has a ceiling value of $6,465.72 and a performance period ending on June 24, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $1,601.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,925,708 units of Tresiba FlexTouch 200 Unit/ML 3ML insulin medication. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a wide range of pharmaceutical and medical supplies...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $1,200.93 worth of Tresiba FlexTouch 200 unit/mL 3mL insulin products. The order has an ultimate completion date of April 8, 2024. This award is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch insulin medication. The contract, valued at $3,001.59, has a period of performance through November 15, 2024 and utilizes a firm fixed price pricing structure. The award is not designated as a set-aside contract. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,805.10, is for the delivery of Tresiba FlexTouch 200 unit/ml 3ml insulin medication. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price delivery order. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
- This is a $23,508.27 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,362,864 units of Tresiba FlexTouch 100 unit/mL 3mL, a prescription insulin product, with a performance period through August 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The contract has a ceiling value of $4,936.67 and an ultimate completion date of September 17, 2024. It is a firm fixed-price contract without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,401.86 to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Tresiba FlexTouch 200 Unit/mL 3mL pharmaceutical products. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,334.04 firm fixed price delivery order contract to AmerisourceBergen Drug Corp to supply Tresiba FlexTouch 100 Unit/mL 3mL insulin products. This delivery order is under a larger indefinite delivery contract with DLA Troop Support Medical, valued up to $999,999,999, which enables the government to efficiently procure a wide range of pharmaceutical and medical supplies to support military healthcare programs. The award does not have a set-aside...